Modulations of behavioral consequences of minor cortical ischemic lesion by application of free radicals scavengers
Language English Country Slovakia Media print
Document type Journal Article, Research Support, Non-U.S. Gov't
- MeSH
- Maze Learning MeSH
- Time Factors MeSH
- Behavior, Animal MeSH
- Cyclic N-Oxides pharmacology MeSH
- Brain Ischemia pathology MeSH
- Ischemia pathology MeSH
- Cognition MeSH
- Rats MeSH
- Melatonin pharmacology MeSH
- Neuroprotective Agents pharmacology MeSH
- Rats, Wistar MeSH
- Reactive Oxygen Species MeSH
- Free Radical Scavengers * MeSH
- Feedback, Sensory MeSH
- Spin Labels MeSH
- Animals MeSH
- Check Tag
- Rats MeSH
- Male MeSH
- Animals MeSH
- Publication type
- Journal Article MeSH
- Research Support, Non-U.S. Gov't MeSH
- Names of Substances
- Cyclic N-Oxides MeSH
- Melatonin MeSH
- Neuroprotective Agents MeSH
- Reactive Oxygen Species MeSH
- Free Radical Scavengers * MeSH
- Spin Labels MeSH
- tempol MeSH Browser
Functional and morphological consequences of ischemic lesions are partially related to the production of reactive oxygen species (ROS). The aim of the study was to create a unilateral photothrombic lesion with minimal morphological changes and minor sensorimotor and cognitive deficits and also to test whether the application of ROS scavengers after the end of induction of ischemia had improved the functional outcome. Adult Wistar male rats were randomly divided into five groups: naive control, sham operated animals, animals with induced ischemia, and two groups of animals with induced ischemia and subsequent ROS scavenger application -melatonin or tempol. The group subjected to ischemia showed a significant decline in performance in sensorimotor tests and the Morris water maze (MWM) test, compared to control animals. Tempol (50 mg/kg, i.p.) did not improve sensorimotor function and did not change spatial learning. Melatonin (100 mg/kg, i.p.), on the contrary, resulted in a significant improvement in animals' performances. All the ischemia subjected animals had increased speed of swimming in the MWM test, compared to the control group. Our findings showed that subsequent application of ROS scavengers improve ischemia outcomes, with melatonin being more potent. Conversely, neither melatonin, nor tempol decreased swimming speed cased by ischemia.
References provided by Crossref.org
Perinatal hypoxic-ischemic damage: review of the current treatment possibilities